ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_1/article-pS-1.xml NCCN Task Force Report: Optimizing Treatment of Advanced Renal Cell Carcinoma With Molecular Targeted Therapy 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/2/article-p133.xml NCCN Guidelines and the International Community 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/2/article-p136.xml Invasive Breast Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/2/article-p225.xml Is There a Need for Axillary Dissection in Breast Cancer? 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/2/article-p233.xml Inflammatory Breast Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/2/article-p243.xml Trastuzumab-Related Cardiac Dysfunction 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/2/article-p251.xml Role of Adjuvant and Posttreatment Exercise Programs in Breast Health 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/2/article-plviii.xml Oncology Research Program 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/2/article-pxlii.xml NCCN News 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_2/article-pS-1.xml NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pvii.xml New NCCN Program Recognizes Organizations Supporting Coverage for Clinical Trials and Appropriate Off-Label Drug Usage 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-px.xml NCCN Trends 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pS-1.xml Take Your Medicine 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pS-2.xml A Quick REMS Update and a Clinical Focus 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pS-4.xml Informing Patients: Translating the NCCN Guidelines 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pS-6.xml Biosimilars: Approval and Acceptance? 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pS-10.xml Where Your Data Is Going and Where It's Been 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pS-13.xml New Options for the Management of Castration-Resistant Prostate Cancer: A Case Perspective 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pS-25.xml Pharmacotherapy for Chronic Myelogenous Leukemia: A Case-Based Approach 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/Suppl_3/article-pS-36.xml Safe and Successful Implementation of CPOE for Chemotherapy at a Children's Cancer Center 2019-01-02